Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1986 2
1989 1
1994 2
2003 2
2007 1
2012 1
2013 1
2014 2
2018 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grünhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, Dürk H, Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W; Study group indolent Lymphomas (StiL). Rummel MJ, et al. Lancet. 2013 Apr 6;381(9873):1203-10. doi: 10.1016/S0140-6736(12)61763-2. Epub 2013 Feb 20. Lancet. 2013. PMID: 23433739 Clinical Trial.
Targeted Next-Generation Sequencing Is a Sensitive Tool for Differential Diagnosis of Myelodysplastic Syndromes in Bone Marrow Trephines.
Bräuninger A, Blau W, Kunze K, Desch AK, Brobeil A, Tur MK, Etschmann B, Günther U, Körholz D, Schliesser G, Käbisch A, Kiehl M, Rummel M, Gattenlöhner S. Bräuninger A, et al. Among authors: kabisch a. J Mol Diagn. 2018 May;20(3):344-354. doi: 10.1016/j.jmoldx.2018.01.006. Epub 2018 Feb 19. J Mol Diagn. 2018. PMID: 29471115 Free article.
Detection of an activated JAK3 variant and a Xq26.3 microdeletion causing loss of PHF6 and miR-424 expression in myelodysplastic syndromes by combined targeted next generation sequencing and SNP array analysis.
Kunze K, Gamerdinger U, Leßig-Owlanj J, Sorokina M, Brobeil A, Tur MK, Blau W, Burchardt A, Käbisch A, Schliesser G, Kiehl M, Rosenwald A, Rummel M, Grimminger F, Hain T, Chakraborty T, Bräuninger A, Gattenlöhner S. Kunze K, et al. Among authors: kabisch a. Pathol Res Pract. 2014 Jun;210(6):369-76. doi: 10.1016/j.prp.2014.02.006. Epub 2014 Feb 23. Pathol Res Pract. 2014. PMID: 24674452
Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma.
McClanahan F, Hielscher T, Rieger M, Hensel M, Bentz M, Schmidt-Wolf I, Käbisch A, Salwender H, Dürk H, Staiger H, Mandel T, Neben K, Hillengass J, Leo E, Krämer A, Ho AD, Witzens-Harig M. McClanahan F, et al. Among authors: kabisch a. Am J Hematol. 2012 Oct;87(10):E68-71. doi: 10.1002/ajh.23286. Epub 2012 Jul 27. Am J Hematol. 2012. PMID: 22847344 Free article. Clinical Trial. No abstract available.
Role of LDL receptor-related protein (LRP) in coronary atherosclerosis.
Schulz S, Birkenmeier G, Schagdarsurengin U, Wenzel K, Müller-Werdan U, Rehfeld D, Süss T, Kabisch A, Werdan K, Gläser C. Schulz S, et al. Among authors: kabisch a. Int J Cardiol. 2003 Dec;92(2-3):137-44. doi: 10.1016/s0167-5273(03)00090-1. Int J Cardiol. 2003. PMID: 14659844
16 results